PXYN — Praxsyn Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $2.92m
- $66.60m
Annual income statement for Praxsyn, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2010 December 31st | C2011 December 31st | C2012 December 31st | R2013 December 31st | 2014 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.35 | 1.58 | 0 | 6.99 | 66.6 |
Cost of Revenue | |||||
Gross Profit | -0.24 | -0.237 | — | 6.29 | 63 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.15 | 6.4 | 2.71 | 3.83 | 40.3 |
Operating Profit | -3.8 | -4.81 | -2.71 | 3.16 | 26.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.06 | -7.51 | -0.878 | 0.77 | -12.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.06 | -7.51 | -0.879 | 0.23 | -12.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.06 | -7.51 | -1.22 | 0.23 | -12.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -4.06 | -7.51 | -1.22 | 0.23 | -12.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.125 | -0.167 | -0.003 | 0.001 | -0.046 |
Dividends per Share |